CD49d prevails over the novel recurrent mutations as independent prognosticator of overall survival in chronic lymphocytic leukemia.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/F03CC330.svg?ark=w1%2F20260517%2FF03CC330&value=id)](https://nobleid.org/work/w1/20260517/F03CC330)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors